Fundraising Fox
Clearsense
Jacksonville, US · Delaware corporation · 105 employees on LinkedIn · 4 known investors
Find your way into Clearsense
Sign up to see every warm intro you have to Clearsense
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Clearsense team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Clearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views. The company targets health systems to reduce costs, improve operational efficiency, accelerate research and impact care outcomes.
Founders & leadership
KM
JR
Jason RoseChief Executive Officer and Board MemberHe previously served as CEO of AdhereHealth, a medication adherence technology company, and held executive leadership roles at Inovalon, where he contributed to product development and strategic partnerships prior to the company's IPO. He holds an MHSA from The George Washington University School of Business and a B.S. in psychology from Radford University.
MH
Matt HendersonChief Compliance Officer and General Counsel
JC
WG
Wirick GlennChief Commercial Officer
ES
Eugene ScheurerNamed on SEC filing
DG
Daniel GallesNamed on SEC filing
JM
Jason MabryNamed on SEC filing
Board
CB
Charles BooradyBoard directorManaging Partner at Health Catalyst Capital
CS
Curtis StratmanBoard director
AW
Anthony WilliamsBoard director
AP
Albert PrastBoard director
Investors · 4
Health Catalyst Capital✓ confirmed by ClearsenseNew York
How we know: Health Catalyst Capital's portfolio page · the company's own site · board seat on SEC Form D · funding news · clearsense.com · Not right? Tell us
HealthQuest Capital✓ confirmed by ClearsenseRedwood City
How we know: the company's own site · funding news · clearsense.com · Not right? Tell us
Kairos Venture Investments, Llclisted by Kairos Venture Investments, LlcBeverly Hills · $150K – $20M
How we know: Kairos Venture Investments, Llc's portfolio page · Not right? Tell us
UPMC EnterprisesreportedPittsburgh
How we know: funding news · clearsense.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$131M disclosed across 11 rounds · 2018–2026
▶$5MraisedApr 2026 · 8 investors · OtherRule 506(b)
▶$5MraisedApr 2026 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Jonathan CookExecutive Officer
- Terry ShawDirector
- Kirk MoquinDirector
- Jason RoseExecutive Officer, Director
- Charles BooradyDirector
- Curtis StratmanDirector
- Ken MischExecutive Officer
- Sam BraschDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Mar 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.4MraisedSep 2024 · 6 investors · Other TechnologyRule 506(b)
▶$5.4MraisedSep 2024 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles BooradyDirector
- Anthony WilliamsDirector
- Albert PrastDirector
- Ken MischExecutive Officer
- Jason RoseExecutive Officer, Director
- Matt HendersonExecutive Officer
- Jonathan CookExecutive Officer
- Kirk MoquinDirector
- Wirick GlennExecutive Officer
- Curtis StratmanDirector
- Offering amount
- $12.5M
- Amount sold
- $5.4M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$13.3MraisedApr 2024 · 8 investors · Other TechnologyRule 506(b)
▶$13.3MraisedApr 2024 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Charles BooradyDirector
- Kirk MoquinDirector
- Albert PrastDirector
- Matt HendersonExecutive Officer
- Jason RoseExecutive Officer, Director
- Anthony WilliamsDirector
- Curtis StratmanDirector
- Todd CreechExecutive Officer
- Offering amount
- $20.3M
- Amount sold
- $13.3M
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2MraisedFeb 2023 · 1 investors · Other TechnologyRule 506(b)
▶$2MraisedFeb 2023 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kirk MoquinDirector
- Matt HendersonExecutive Officer
- Kevin FieldExecutive Officer
- Eugene ScheurerExecutive Officer, Director
- Charles BooradyDirector
- Anthony WilliamsDirector
- Lee WesterfieldExecutive Officer
- Albert PrastDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$49.9MraisedFeb 2023 · 8 investors · Other TechnologyRule 506(b)
▶$49.9MraisedFeb 2023 · 8 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Albert PrastDirector
- Daniel WildermuthDirector
- Charles BooradyDirector
- Daniel GallesDirector
- Kevin FieldExecutive Officer, Director
- Lee WesterfieldExecutive Officer
- Kirk MoquinDirector
- Matt HendersonExecutive Officer
- Eugene ScheurerExecutive Officer, Director
- Offering amount
- $58.4M
- Amount sold
- $49.9M
- Sales commissions
- $2.3M
- Placement agents
- Piper Sandler & Co.
- First sale
- Jan 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MraisedDec 2022 · 5 investors · Other TechnologyRule 506(b)
▶$2.5MraisedDec 2022 · 5 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kirk MoquinDirector
- Eugene ScheurerExecutive Officer, Director
- Dan WildermuthDirector
- Albert PrastDirector
- Charles BooradyDirector
- Daniel GallesDirector
- Kevin FieldExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $2.5M
- First sale
- Dec 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$5.7MraisedSep 2022 · 6 investors · Other TechnologyRule 506(b)
▶$5.7MraisedSep 2022 · 6 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Eugene ScheurerExecutive Officer, Director
- Charles BooradyDirector
- Albert PrastDirector
- Daniel GallesDirector
- Dan WildermuthDirector
- Kevin FieldExecutive Officer, Director
- Kirk MoquinDirector
- Offering amount
- $10M
- Amount sold
- $5.7M
- First sale
- Sep 2022
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1MraisedSep 2021 · 1 investors · Other TechnologyRule 506(b)
▶$1MraisedSep 2021 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Kevin FieldExecutive Officer, Director
- Randall RobinsonExecutive Officer
- Albert PrastDirector
- Daniel GallesDirector
- Charles BooradyDirector
- Matt HendersonDirector
- Kirk MoquinDirector
- Dan WildermuthDirector
- Eugene ScheurerExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1M
- First sale
- Aug 2021
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 5
SisenseSisense provides embedded analytics software that enables teams to integrate data visualization and insights into business applications. The platform serves product development teams and enterprises seeking to build data-driven features into their software products.
uBiomeAccount engagement platform helping B2B organizations achieve predictable revenue growth.
TeamSenseTeamSense is an AI-powered, text-based platform that automates attendance tracking, absence reporting, and multilingual worker communication for frontline teams, syncing with HRIS systems. It serves manufacturing and logistics operations, helping managers manage call-offs, coverage, and employee engagement.
SwipeSenseSwipeSense is a healthcare technology company that provides a hospital safety platform with applications for electronic hand hygiene monitoring, real-time asset tracking, automated contact tracing, and nursing insights. It serves hospitals in the U.S., helping them prevent infections, optimize equipment use, and improve patient and staff experiences through data-driven insights.
InfusenseInfuSense develops an electrochemical sensing technology platform that detects analytes at sub-therapeutic levels, delivering sample analysis results within minutes. The portable device is designed to bring laboratory-scale testing capabilities into a handheld form factor.
Companies working in the same space as Clearsense.
In the news
Frequently asked questions
- What does Clearsense do?
- Clearsense operates the 1Clearsense Platform, a healthcare data lakehouse that unifies and manages disparate data for health systems and presents it in simplified, actionable views. The company targets health systems to reduce costs, improve operational efficiency, accelerate research and impact care outcomes.
- Who are Clearsense's investors?
- Clearsense's investors include Health Catalyst Capital, HealthQuest Capital, Kairos Venture Investments, Llc, UPMC Enterprises.
- How much funding has Clearsense raised?
- Clearsense has disclosed $131M raised across 11 rounds.
- Where is Clearsense headquartered?
- Clearsense is headquartered in Jacksonville, US.